(Q40932326)

25 September 2017

title

Papillomavirus E2 induces p53-independent apoptosis in HeLa cells (English)

1 reference

25 September 2017

Desaintes C

1 reference

25 September 2017

Goyat S

1 reference

25 September 2017

Garbay S

1 reference

25 September 2017

Yaniv M

1 reference

25 September 2017

Thierry F

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

4538-4545

1 reference

The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

Induction of DNA synthesis and apoptosis are separable functions of E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

Genetic determinants of p53-induced apoptosis and growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Amino-terminal domains of the bovine papillomavirus type 1 E1 and E2 proteins participate in complex formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Functional interaction of a novel cellular protein with the papillomavirus E2 transactivation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Distinct roles for E2F proteins in cell growth control and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Control of HPV 18 DNA replication by cellular and viral transcription factors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Expression of the papillomavirus E2 protein in HeLa cells leads to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

E2F-1 functions in mice to promote apoptosis and suppress proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Induction of apoptosis in HeLa cells by trans-activation-deficient p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Crystal structure at 1.7 A of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

The bovine papillomavirus type 1 (BPV1) replication protein E1 modulates transcriptional activation by interacting with BPV1 E2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

The acidic transcriptional activation domains of VP16 and p53 bind the cellular replication protein A and stimulate in vitro BPV-1 DNA replication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

The bovine papillomavirus 1 E2 protein contains two activation domains: one that interacts with TBP and another that functions after TBP binding.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Cooperative activation of transcription by bovine papillomavirus type 1 E2 can occur over a large distance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

p21 is a universal inhibitor of cyclin kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202818

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202818

1 reference

Dimensions Publication ID

25 September 2017

1028012162

0 references

1 reference